Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects

Journal of Clinical Investigation

Volumn 95, Issue 6, 1995, Pages 2806-2812

  Ahmad, Faiyaz ^a   Considine, Robert V ^a   Goldstein, Barry J ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

hormone signalling; insulin resistance; tyrosine kinase; tyrosine phosphorylation

Indexed keywords

INSULIN; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE;

ADIPOSE TISSUE; ARTICLE; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; OBESITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0029018196     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117985     Document Type: Article

References (56)

1. Rabinowitz, D. 1970. Some endocrine and metabolic aspects of obesity. Annu. Rev. Med. 21:241-258.
2. Kolterman, O. G., J. Insel, M. Saekow, and J. M. Olefsky. 1980. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J. Clin. Invest. 65:1272-1284.
3. Caro, J. F., L. G. Dohm, W. J. Pories, and M. K. Sinha. 1989. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. [Review]. Diabetes-Metab. Rev. 5:665-689.
4. White, M. F., and C. R. Kahn. 1994. The insulin signalling system. J. Biol. Chem. 269:1-4.
5. Goldstein, B. J. 1993. Regulation of insulin receptor signalling by protein-tyrosine dephosphorylation. Receptor. 3:1-15.
6. Fischer, E. H., H. Charbonneau, and N. K. Tonks. 1991. Protein tyrosine phosphatases-A diverse family of intracellular and transmembrane enzymes. Science (Wash. DC). 253:401-406.
7. Streuli, M., N. X. Krueger, L. R. Hall, S. F. Schlossman, and H. Saito. 1988. A new member of the immunoglobulin superfamily that has a cytoplasmic region homologous to the leukocyte common antigen. J. Exp. Med. 168:1523-1530.
8. Chernoff, J., A. R. Schievella, C. A. Jost, R. L. Erikson, and B. G. Neel. 1990. Cloning of a cDNA for a major human protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA. 87:2735-2739.
9. Guan, K. L., R. S. Haun, S. J. Watson, R. L. Geahlen, and J. E. Dixon. 1990. Cloning and expression of a protein-tyrosine-phosphatase. Proc. Natl. Acad. Sci. USA. 87:1501-1505.
10. Freeman, R. M., J. Plutzky, and B. G. Neel. 1992. Identification of a Human src Homology 2-Containing Protein-Tyrosine-Phosphatase. A putative homolog of Drosophila corkscrew. Proc. Natl. Acad. Sci. USA. 89:11239-11243.
11. Ahmad, S., D. Banville, Z. Z. Zhao, E. H. Fischer, and S. H. Shen. 1993. A widely expressed human protein-tyrosine phosphatase containing src homology-2 domains. Proc. Natl. Acad. Sci. USA. 90:2197-2201.
12. Ding, W., W. R. Zhang, K. Sullivan, N. Hashimoto, and B. J. Goldstein. 1994. Identification of protein-tyrosine phosphatases prevalent in adipocytes by molecular cloning. Biochem. Biophys. Res. Commun. 202:902-907.
13. Mooney, R. A., and D. L. Anderson. 1989. Phosphorylation of the insulin receptor in permeabilized adipocytes is coupled to a rapid dephosphorylation reaction. J. Biol. Chem. 264:6850-6857.
14. Bernier, M., A. S. Liotta, H. K. Kole, D. D. Shock, and J. Roth. 1994. Dynamic regulation of intact and C-terminal truncated insulin receptor phosphorylation in permeabilized cells. Biochemistry. 33:4343-4351.
15. Hashimoto, N., E. P. Feener, W. R. Zhang, and B. J. Goldstein. 1992. Insulin receptor protein-tyrosine phosphatases. Leukocyte common antigen-related phosphatase rapidly deactivates the insulin receptor kinase by preferential dephosphorylation of the receptor regulatory domain. J. Biol. Chem. 267:13811-13814.
16. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
17. Kasuga, M., M. F. White, and C. R. Kahn. 1985. Phosphorylation of the insulin receptor in cultured hepatoma cells and a solubilized system. Methods Enzymol. 109:609-621.
18. Laemmli, E. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
19. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
20. Hashimoto, N., W. R. Zhang, and B. J. Goldstein. 1992. Insulin receptor and epidermal growth factor receptor dephosphorylation by three major rat liver protein-tyrosine phosphatases expressed in a recombinant bacterial system. Biochem. J. 284:569-576.
21. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
22. Milarski, K. L., and A. R. Saltiel. 1994. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269:21239-21243.
23. Xiao, S., D. W. Rose, T. Sasaoka, H. Maegawa, T. R. Burke, P. P. Roller, S. E. Shoelson, and J. M. Olefsky. 1994. Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J. Biol. Chem. 269:21244-21248.
24. Caro, J. F. 1991. Clinical Review 26: Insulin resistance in obese and nonobese man. J. Clin. Endocrinol. Metab. 73:691-695.
25. Campbell, P. J., and J. E. Gerich. 1990. Impact of obesity on insulin action in volunteers with normal glucose tolerance: Demonstration of a threshold for the adverse effect of obesity. J. Clin. Endocrinol. Metab. 70:1114-1118.
26. Boden, O. 1993. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care. 16:728-733.
27. Reaven, G. M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
28. Olefsky, J. M. 1976. Insulin binding to adipocytes and circulating monocytes from obese patients. J. Clin. Invest. 57:1165-1172.
29. Ciaraldi, T. P., J. M. Molina, and J. M. Olefsky. 1991. Insulin action kinetics in adipocytes from obese and noninsulin-dependent diabetes mellitus subjects: identification of multiple cellular defects in glucose transport. J. Clin. Endocrinol. Metab. 72:876-882.
30. Freidenberg, G. R., R. R. Henry, H. H. Klein, D. R. Reichart, and J. M. Olefsky. 1987. Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J. Clin. Invest. 79:240-250.
31. Takayama, S., C. R. Kahn, K. Kubo, and J. E. Foley. 1988. Alterations in insulin receptor autophosphorylation in insulin resistance: Correlation with altered sensitivity to glucose transport and anti-lipolysis to insulin. J. Clin. Endocrinol. Metab. 66:992-990.
32. Sinha, M. K., W. J. Pories, E. G. Flickinger, D. Meelheim, and J. F. Caro. 1987. Insulin-receptor kinase activity of adipose tissue from morbidly obese humans with and without NIDDM. Diabetes. 36:620-625.
33. Meyerovitch, J., P. L. Rothenberg, Y. Shechter, S. Bonner-Weir, and C. R. Kahn. 1991. Vanadate normalizes hyperglycemia in two mouse models of non-insulin dependent diabetes mellitus. J. Clin. Invest. 87:1286-1294.
34. Posner, B. I., R. Faure, J. W. Burgess, A. P. Bevan, D. Lachance, G. Y. Zhangsun, I. G. Fantus, J. B. Ng, D. A. Hall, B. S. Lum, and A. Shaver. 1994. Peroxovanadium compounds: a new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 269:4596-4604.
35. Shisheva, A., O. Ikonomov, and Y. Shechter. 1994. The protein tyrosine phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated diabetic rats. Endocrinology. 134:507-510.
36. Meyerovitch, J., J. M. Backer, and C. R. Kahn. 1989. Hepatic phosphotyrosine phosphatase activity and its alteration in diabetic rats. J. Clin. Invest. 84:976-983.
37. Begum, N., K. E. Sussman, and B. Draznin. 1991. Differential Effects of Diabetes on Adipocyte and Liver Phosphotyrosine and Phosphoserine Phosphatase Activities. Diabetes. 40:1620-1629.
38. Boylan, J. M., D. L. Brautigan, J. Madden, T. Raven, L. Ellis, and P. A. Gruppuso. 1992. Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats. J. Clin. Invest. 90:174-179.
39. Goren, H. J., and D. Boland. 1991. The 180,000 Molecular weight plasma membrane insulin receptor substrate is a protein tyrosine phosphatase and is elevated in diabetic plasma membranes. Biochem. Biophys. Res. Commun. 180:463-469.
40. Nadiv, O., M. Shinitzky, H. Manu, D. Hecht, C. T. Roberts, Jr., D. LeRoith, and Y. Zick. 1994. Elevated protein tyrosine phosphatase activity and increased membrane viscosity are associated with impaired activation of the insulin receptor kinase in old rats. Biochem. J. 298:443-450.
41. McGuire, M. C., R. M. Fields, B. L. Nyomba, I. Raz, C. Bogardus, N. K. Tonks, and J. Sommercorn. 1991. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes. 40:939-942.
42. Kusari, J., K. A. Kenner, K. I. Suh, D. E. Hill, and R. R. Henry. 1994. Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance. J. Clin. Invest. 93:1156-1162.
43. Ahmad, F., and B. J. Goldstein. 1995. Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of obesity and insulin resistance. Metabolism. In press.
44. Kulas, D. T., W. R. Zhang, B. J. Goldstein, R. W. Furlanetto, and R. A. Mooney. 1995. Insulin receptor signalling is augmented by antisense inhibition of the protein-tyrosine phosphatase LAR. J. Biol. Chem. 270:2435-2438.
45. Charbonneau, H., N. K. Tonks, S. Kumar, C. D. Diltz, M. Harrylock, D. E. Cool, E. G. Krebs, E. H. Fischer, and K. A. Walsh. 1989. Human placenta protein-tyrosine-phosphatase: amino acid sequence and relationship to a family of receptor-like proteins. Proc. Natl. Acad. Sci. USA. 86:5252-5256.
46. Lammers, R., B. Bossenmaier, D. E. Cool, N. K. Tonks, J. Schlessinger, E. H. Fischer, and A. Ullrich. 1993. Differential activities of protein tyrosine phosphatases in intact cells. J. Biol. Chem. 268:22456-22462.
47. Sun, X. J., D. L. Crimmins, M. G. Myers, M. Miralpeix, and M. F. White. 1993. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol. Cell. Biol. 13:7418-7428.
48. Kuhné, M. R., T. Pawson, G. E. Lienhard, and G. S. Feng. 1993. The Insulin Receptor Substrate-1 Associates with the SH2-Containing Phosphotyrosine Phosphatase Syp. J. Biol. Chem. 268:11479-11481.
49. Sugimoto, S., T. J. Wandless, S. E. Shoelson, B. G. Neel, and C. T. Walsh. 1994. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J. Biol. Chem. 269:13614-13622.
50. Maegawa, H., S. Ugi, O. Ishibashi, R. Tachikawaide, N. Takahara, Y. Tanaka, Y. Takagi, R. Kikkawa, Y. Shigeta, and A. Kashiwagi. 1993. Src homology-2 domains of protein tyrosine phosphatase are phosphorylated by insulin receptor kinase and bind to the COOH-terminus of insulin receptors in vitro. Biochem. Biophys. Res. Commun. 194:208-214.
51. Maegawa, H., S. Ugi, M. Adachi, Y. Hinoda, R. Kikkawa, A. Yachi, Y. Shigeta, and A. Kashiwagi. 1994. Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing SRC homology 2 regions and modulates its PTPase activity in vitro. Biochem. Biophys. Res. Commun. 199:780-785.
52. Ugi, S., H. Maegawa, J. M. Olefsky, Y. Shigeta, and A. Kashiwagi. 1994. Src homology 2 domains of protein tyrosine phosphatase are associated in vitro with both the insulin receptor and insulin receptor substrate-1 via different phosphotyrosine motifs. FEBS (Fed. Eur. Biochem. Soc.) Lett. 340:216-220.
53. Vogel, W., R. Lammers, J. T. Huang, and A. Ullrich. 1993. Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science (Wash. DC). 259:1611-1614.
54. Kuhné, M. R., Z. Z. Zhao, J. Rowles, B. E. Lavan, S. H. Shen, E. H. Fischer, and G. E. Lienhard. 1994. Dephosphorylation of insulin receptor substrate 1 by the tyrosine phosphatase PTP2C. J. Biol. Chem. 269:15833-15837.
55. Streuli, M., N. X. Krueger, P. D. Ariniello, M. Tang, J. M. Munro, W. A. Blattler, D. A. Adler, C. M. Disteche, and H. Saito. 1992. Expression of the receptor-linked protein tyrosine phosphatase LAR: proteolytic cleavage and shedding of the CAM-like extracellular region. EMBO (Eur. Mol. Biol. Organ.) J. 11:897-907.
56. Yu, Q., T. Lenardo, and R. A. Weinberg. 1992. The N-terminal and C-terminal domains of a receptor tyrosine phosphatase are associated by non-covalent linkage. Oncogene. 7:1051-1058.